Synthesis and characterization of ethosomal contrast agents containing iodine for computed tomography (CT) imaging applications

References

• Ainbinder D, Paolino D, Fresta M, Touitou E. (2010). Drug delivery applications with ethosomes. J Biomed Nanotechnol 6:558–68
   PubMed Web of Science ®Google Scholar
• Al-Jamal WT, Kostarelos K. (2011). Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Accounts Chem Res 44:1094–104
   PubMed Web of Science ®Google Scholar
• Baron RL. (1994). Understanding and optimizing use of contrast material for CT of the liver. AJR Am J Roentgenol 163:323–31
   PubMed Web of Science ®Google Scholar
• Biruss B, Valenta C. (2006). Skin permeation of different hormones from polymeric coated liposomal formulations. Eur J Pharm Biopharm 62:210–19
   PubMed Web of Science ®Google Scholar
• Campli CD, Wu J, Zern MA. (1999). Targeting of therapeutics to the liver: liposomes and viral vectors. Alcohol Clin Exp Res 23:950–4
   PubMed Web of Science ®Google Scholar
• Celia C, Cilurzo F, Trapasso E, et al. (2012). Ethosomes (R) and transfersomes (R) containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders. Biomed Microdevices 14:119–30
   PubMed Web of Science ®Google Scholar
• Cortesi R, Romagnoli R, Drechsler M, et al. (2010). Liposomes- and ethosomes-associated distamycins: a comparative study. J Liposome Res 20:277–85
   PubMed Web of Science ®Google Scholar
• Dai X, Schlemmer H-P, Schmidt B, et al. (2013). Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib. Eur J Radiol 82:327–34
   PubMed Web of Science ®Google Scholar
• Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21:1879–85
   PubMed Web of Science ®Google Scholar
• Desser TS, Rubin DL, Muller H, et al. (1999). Blood pool and liver enhancement in CT with liposomal iodixanol: comparison with iohexol. Acad Radiol 6:176–83
   PubMed Web of Science ®Google Scholar
• Elrod DB, Partha R, Danila D, et al. (2009). An iodinated liposomal computed tomographic contrast agent prepared from a diiodophosphatidylcholine lipid. Nanomed-Nanotechnol 5:42–5
   PubMed Web of Science ®Google Scholar
• Gaillard PJ, Appeldoorn CCM, Rip J, et al. (2012). Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J Control Rel 164:364–9
   PubMed Web of Science ®Google Scholar
• Hyafil F, Cornily J-C, Feig JE, et al. (2007). Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 13:636–41
   PubMed Web of Science ®Google Scholar
• Kao C-Y, Hoffman EA, Beck KC, et al. (2003). Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging. Acad Radiol 10:475–83
   PubMed Web of Science ®Google Scholar
• Katayama H, Spinazzi A, Fouillet X, et al. (2001). Iomeprol: current and future profile of a radiocontrast agent. Invest Radiol 36:87–96
   PubMed Web of Science ®Google Scholar
• Kemmerer SR, Mortele KJ, Ros PR. (1998). CT scan of the liver. Radiol Clin North Am 36:247–60
   PubMed Web of Science ®Google Scholar
• Leander P, Hoglund P, Borseth A, et al. (2001). A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety. Eur Radiol 11:698–704
   PubMed Web of Science ®Google Scholar
• Leung SJ, Romanowski M. (2012). Molecular catch and release: controlled delivery using optical trapping with light-responsive liposomes. Adv Mater 24:6380–3
   PubMed Web of Science ®Google Scholar
• Longmuir KJ, Haynes SM, Baratta JL, et al. (2009). Liposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparin sulfate. Int J Pharmaceut 382:222–33
   PubMed Web of Science ®Google Scholar
• Montet X, Pastor CM, Vallee J-P, et al. (2007). Improved visualization of vessels and hepatic tumors by micro-computed tomography (CT) using iodinated liposomes. Invest Radiol 42:652–8
   PubMed Web of Science ®Google Scholar
• Paolino D, Lucania G, Mardente D, et al. (2005). Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Rel 106:99–110
   PubMed Web of Science ®Google Scholar
• Touitou E, Dayan N, Bergelson L, et al. (2000). Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Rel 65:403–18
   PubMed Web of Science ®Google Scholar
• Xing XJ, Yang L, You Y, et al. (2011). Study of the biological function and penetration pathways of the mouse epidermal growth factor ethosomal delivery system. Exp Dermatol 20:945–7
   PubMed Web of Science ®Google Scholar
• Zheng J, Liu J, Dunne M, et al. (2007). In vivo performance of a liposomal vascular contrast agent for CT and MR-based image guidance applications. Pharm Res 24:1193–201
   PubMed Web of Science ®Google Scholar